Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.

MLA

Ozawa, Yuichi, et al. “Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.” Anticancer Research, vol. 38, no. 10, Oct. 2018, pp. 5937–41. EBSCOhost, https://doi.org/10.21873/anticanres.12939.

APA

Ozawa, Y., Koda, K., Akahori, D., Matsui, T., Hasegawa, H., Kakutani, T., Amano, T., Tanahashi, M., Niwa, H., Kunimoto, Y., Yamada, K., Yokomura, K., & Suda, T. (2018). Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms. Anticancer Research, 38(10), 5937–5941. https://doi.org/10.21873/anticanres.12939

Chicago

Ozawa, Yuichi, Keigo Koda, Daisuke Akahori, Takashi Matsui, Hirotsugu Hasegawa, Takuya Kakutani, Tusuke Amano, et al. 2018. “Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.” Anticancer Research 38 (10): 5937–41. doi:10.21873/anticanres.12939.